NCT05417594: Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 695 planned
- Started
- 24 Jun 2022
- Primary completion
- 7 Feb 2028
- Arms
- Module 2 Part A: Dose escalation
- Results
- None posted
- 14 Jun 2022: Trial registered
- 24 Jun 2022: Trial started